A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpoints (Q6560473)
From MaRDI portal
| This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpoints |
scientific article; zbMATH DE number 7869930
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpoints |
scientific article; zbMATH DE number 7869930 |
Statements
A Bayesian phase II proof-of-concept design for clinical trials with longitudinal endpoints (English)
0 references
23 June 2024
0 references
Bayesian phase II design
0 references
longitudinal endpoint
0 references
pain management
0 references
proof-of-concept design
0 references